ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $39,538,000 | -26.7% | 2,650,000 | +26.2% | 1.11% | -17.1% |
Q3 2021 | $53,970,000 | +68.9% | 2,100,000 | +71.4% | 1.34% | +65.6% |
Q2 2021 | $31,948,000 | -30.4% | 1,225,000 | -5.8% | 0.81% | -40.7% |
Q1 2021 | $45,890,000 | +92.4% | 1,300,000 | +37.6% | 1.37% | +93.4% |
Q4 2020 | $23,852,000 | -33.1% | 945,000 | 0.0% | 0.71% | -55.7% |
Q3 2020 | $35,636,000 | +33.2% | 945,000 | +51.2% | 1.60% | +0.8% |
Q2 2020 | $26,763,000 | +175.3% | 625,000 | +25.0% | 1.58% | +53.5% |
Q1 2020 | $9,720,000 | – | 500,000 | – | 1.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |